Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis
Clinical Medicine|更新时间:2026-01-09
|
Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis
Journal of Army Medical UniversityVol. 44, Issue 3, Pages: 241-245(2022)
作者机构:
400038 重庆,陆军军医大学(第三军医大学)第一附属医院急救部
作者简介:
基金信息:
the General Project of Technology Innovation and Application Development Program of Chongqing(cstc2019jscx-msxmX0222);the Special Project of Science and Technology Innovation Ability Promotion of Army Medical University(2019XLC3001)
Yang LI, Yinjie ZHAO, Haiyan YU, et al. Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis[J]. Journal of Army Medical University, 2022, 44(3): 241-245.
DOI:
Yang LI, Yinjie ZHAO, Haiyan YU, et al. Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis[J]. Journal of Army Medical University, 2022, 44(3): 241-245. DOI: 10.16016/j.2097-0927.202107019.
Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis
To explore the predictive value of soluble urokinase-type plasminogen activator receptor (suPAR) for severe acute pancreatitis (SAP).
Methods
2
A prospective cohort study was designed to enroll 103 patients with acute pancreatitis who were admitted to our department from March 1 to June 1
2021
including 23 SAP and 80 non-severe acute pancreatitis (NSAP). Another 30 healthy subjects were recruited concurrently as control group. The plasma samples of all subjects were collected on the first day of admission to detect the level of suPAR using ELISA. General clinical data and the levels of procalcitonin (PCT)
interleukin-6 (IL-6)
C-reactive protein (CRP)
D-dimer and serum calcium (Ca
2+
)
as well as the results of blood routine and biochemical examinations of patients were all collected. Acute Physiology and Chronic Health Evaluation (APACHEⅡ) score and Ranson's score were subsequently calculated. For the control subjects
only their demographic characteristics (age and gender) were collected. Statistical analysis was adopted on the above data.
Results
2
The plasma suPAR level was significantly higher in the patients with NSAP and SAP than the control group (
P
<
0.05)
and also notably higher in those of the SAP group than those out of the NSAP patients (
P
<
0.05). Pearson correlation ana
lysis showed that plasma suPAR level was positively correlated with both APACHE Ⅱ score and Ranson's score (
R
=0.554
R
=0.485
P
<
0.05). Multivariate Logistic regression analysis indicated that suPAR
D-dimer and Ca
2+
levels were independent predictors of SAP. ROC curve demonstrated that serum suPAR had a good predictive value for SAP (AUC=0.869).
Conclusion
2
The plasma level of suPAR is closely correlated with the severity of acute pancreatitis
ZHU W Y, DU S S, HE J L, et al . Superimposed effect of glutamine supplementation by different pathways on serum albumin in severe acute pancreatitis patients[J ] . J Third Mil Med Univ, 2016, 38(3): 284-287. DOI: 10.16016/j.1000-5404.201506 031.
HUANG Q R, XIONG H Y, YAN P J, et al . The diagnostic and prognostic value of suPAR in patients with sepsis: a systematic review and meta-analysis[J ] . Shock, 2020, 53(4): 416-425. DOI: 10.1097/shk.0000000000001434.
LIU K L, FAN J H, WU J. Prognostic role of circulating soluble uPAR in various cancers: a systematic review and meta-analysis[J]. Clin Lab, 2017, 63(5): 871-880. DOI: 10.7754/clin.lab.2017.170110.
KOCH A, ZIMMERMANN H W, GASSLER N, et al . Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure[J ] . Liver Int, 2014, 34(9): 1330-1339. DOI: 10.1111/liv.12512.
WANG X P, LI Z S, YUAN Y Z, et al . Guidelines for diagnosis and treatment of acute pancreatitis in China (2013, Shanghai)[J ] . Chin J Gastroenterol, 2013, 18(7): 428-433. DOI: 10.3969/j.issn.1008-7125.2013.07.010.
BANKS P A, BOLLEN T L, DERVENIS C, et al . Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus[J ] . Gut, 2013, 62(1): 102-111. DOI: 10.1136/gutjnl-2012-302779.
DU Y Q, CHEN Q K, LI H Y, et al . Chinese guidelines for the management of acute pancreatitis (Shenyang, 2019)[J ] . J Clin Hepatol, 2019, 35(12): 2706-2711. DOI: 10.3969/j.issn.1001-5256.2019.12.013.
ZHOU Y Y, YANG L, LIAO Z L, et al . BISAP score vs Ranson's criteria in predicting outcomes of acute pancreatitis[J ] . J Third Mil Med Univ, 2012, 34(7): 658-661. DOI: 10.16016/j.1000-5404.2012.07.023.
XU Y P, LUO F J, ZHENG J, et al . Clinical value of serum procalcitonin and C-reactive protein in diagnosis of patients with severe acute pancreatitis[J ] . Chin J Nosocomiol, 2017, 27(5): 1089-1092. DOI: 10.11816/cn.ni.2016-162738.
KONG H, DING Z, ZHU X C, et al . Serum D-dimer changes and prognostic implication in acute pancreatitis[J ] . Chin J Intern Med, 2007(12): 1011-1013. DOI: 10.3760/j.issn:0578-1426.2007.12.011.
THUNØ M, MACHO B, EUGEN-OLSEN J. suPAR: the molecular crystal ball[J]. Dis Markers, 2009, 27(3): 157-172. DOI: 10.3233/dma-2009-0657.
GUSTAFSSON A, LJUNGGREN L, BODELSSON M, et al . The prognostic value of suPAR compared to other inflammatory markers in patients with severe sepsis[J ] . Biomark Insights, 2012, 7: 39-44. DOI: 10.4137/bmi.s9460.
LIU B, LI D, HU X, et al . The predictive value of serum calcium for acute pancreatitis with persistent organ failure[J ] . Am J Emerg Med, 2018, 36(4): 726-727. DOI: 10.1016/j.ajem.2017.08.038.
GUSSEN H, HOHLSTEIN P, BARTNECK M, et al . Neutrophils are a main source of circulating suPAR predicting outcome in critical illness[J ] . J Intensive Care, 2019, 7: 26. DOI: 10.1186/s40560-019-0381-5.
PLIYEV B K, MENSHIKOV M Y. Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis[J]. Inflammation, 2010, 33(1): 1-9. DOI: 10.1007/s10753-009-9152-0.
HAHM E, WEI C, FERNANDEZ I, et al . Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease[J ] . Nat Med, 2017, 23(1): 100-106. DOI:10.1038/nm.4242.